Diseases, Conditions, Syndromes

First human trial of monoclonal antibody to prevent malaria opens

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. ...

Diseases, Conditions, Syndromes

A new breakthrough in developing effective antimalarial drugs

Parasites in the genus Plasmodium, which cause malaria, are transmitted to humans through bites from infected mosquitoes. The parasites acclimatize to these two completely different hosts because the plasticity of their genome ...

Diseases, Conditions, Syndromes

Editing mosquito's gene wards off malaria and halts reproduction

Scientists have looked for immune system factors that might help mosquitoes ward off pathogens such as malarial parasites and indirectly protect humans from infection. Yale researchers found one by editing a single gene, ...

Diseases, Conditions, Syndromes

Poverty as a disease trap

No drug can cure a paradox. That basic truth is at the heart of a new Stanford-led study highlighting how poverty traps make it impossible to eradicate a potentially deadly disease with current approaches.

page 8 from 30